June 25, 2020 / 5:26 PM / 19 days ago

BRIEF-Bergenbio Announces Positive Interim Clinical And Translational Data From Phase II Trial Of Bemcentinib In Combination With Keytruda

June 25 (Reuters) - Bergenbio ASA:

* BERGENBIO ANNOUNCES POSITIVE INTERIM CLINICAL AND TRANSLATIONAL DATA FROM PHASE II TRIAL OF BEMCENTINIB IN COMBINATION WITH KEYTRUDA[®] IN CHECKPOINT INHIBITOR REFRACTORY NSCLC PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below